Sponsor pipeline

McGill University Health Centre/Research Institute of the McGill University Health Centre clinical trial pipeline

Get alerts when McGill University Health Centre/Research Institute of the McGill University Health Centre's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

6 trials changed in the last 30 days: 1 stopped, 2 with notable changes, 3 with minor changes only.

  1. Stopped

    Trial terminated

    Also in this update: Primary completion date changed from estimate of Nov 1, 2025 to Sep 22, 2026; Final enrollment: 3 participants (planned 25)

    McGill University Health Centre/Research Institute of the McGill University Health CentreNot specified NCT06315725 Registry history

Show 3 trials with minor changes only
  2. Minor

    Primary completion date changed from estimate of Jul 2026 to Sep 30, 2026

    Also in this update: Study completion pushed from Aug 2026 to Jan 2027

    McGill University Health Centre/Research Institute of the McGill University Health CentreNot applicable NCT06816368 Registry history

  3. Minor

    Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting

    McGill University Health Centre/Research Institute of the McGill University Health CentreNot applicable NCT06559865 Registry history

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07871838 Safety, Efficacy and Quality of Life After Adjuvant Hypofractionated Radiotherapy for… Recruiting
2026-09-30 NCT07850648 The CANadian EXAcerbation of COPD Trial Not Yet Recruiting
2026-09-29 NCT07848204 Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors Phase 1 Completed

Active trials by phase

Early Phase 1
1
Phase 1
2
Phase 2
8
Phase 2/3
4
Phase 3
2
Phase 4
9
Not charted: 71 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 23

Heart Disease (13) · Diabetes (6) · Type 1 Diabetes (4) · Chronic Kidney Disease (3) · Colorectal Cancer (2) · COPD (2) · Coronary Artery Disease (2) · Heart Failure (2) · Lupus (SLE) (2) · Prostate Cancer (2)

Get alerts when McGill University Health Centre/Research Institute of the McGill University Health Centre's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free